Pfizer-BioNTech says their COVID-19 vaccine is 90% effective in kids ages 5 to 11. The Food and Drug Administration is likely to decide on emergency authorization as soon as the last week of October.
Kids under 12 years generally can't get a COVID vaccine. US authorities will rule on emergency approval for the BioNTech-Pfizer jab for 5- to 11-year-olds.
The FDA typically follows the opinions of this panel, which is recommending the authorization of Pfizer’s vaccine for children between the ages of 5 and 11.
A key Food and Drug Administration (FDA) expert advisory panel on Tuesday recommended the agency authorize Pfizer's COVID-19 vaccine for use in children between the ages of 5 and 11, bringing those children one step
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
The FDA's independent vaccine advisory board is meeting to discuss whether the Pfizer/BioNTech Covid-19 vaccine should be authorized for children ages 5 to 11. Follow here for the latest news updates.
In a preliminary analysis last week, Food and Drug Administration reviewers said that protection would "clearly outweigh" the risk of a very rare side effect in almost all scenarios of the pandemic. Now FDA's advisers are combing through that data to see if they agree.
American Opinion: The FDA in May expanded emergency use authorization for the Pfizer COVID-19 vaccine for children ages 12-15. The agency gave full approval of vaccines for everyone 16 and older in late September. The sooner the vaccines receive full approval for all school age children, the better.
If the FDA authorizes the kid-size doses, then next week the Centers for Disease Control and Prevention will have to decide whether to recommend the shots and which youngsters should get them.
A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that’s account…
A US Food and Drug Administration advisory committee recommended Tuesday that the agency grant emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11.
A medical panel of US government advisors endorsed the Pfizer COVID-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.
Vaccine advisers to the US Food and Drug Administration voted 17-0 with one abstention Tuesday to recommend emergency use authorization of Pfizer's COVID-19 vaccine in children ages 5 to 11.
Showing the first 25 of 102 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Is the COVID-19 vaccine safe for kids 5-11? Here's what the evidence shows | Since Then
